Genome-derived cytosolic DNA contributes to type I interferon expression and immunogenicity of B-cell lymphoma cells

Cytokine. 2015 Dec;76(2):581-582. doi: 10.1016/j.cyto.2015.05.024. Epub 2015 Jun 9.

Abstract

We recently provided evidence that genome-derived DNA is present in the cytosol of many tumor cells. Genomic loci that give rise to cytosolic DNA can potentially form non-B DNA structures including triple-stranded RNA:DNA structures (R-loops). The RNA:DNA-specific endonuclease RNaseh1 reduced the levels of cytosolic DNA and type I interferon-dependent rejection of B-cell lymphoma suggesting that cytosolic DNA may contribute to immune surveillance of B-cell lymphoma.

Keywords: Cancer; DNA sensors; Innate immunity; Non-B DNA motifs; Type I interferon.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Line, Tumor
  • DNA / genetics*
  • Genome*
  • Humans
  • Interferon Type I / genetics*
  • Lymphoma, B-Cell / genetics*
  • Lymphoma, B-Cell / immunology*
  • RNA / genetics

Substances

  • Interferon Type I
  • RNA
  • DNA